CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Astellas Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Astellas Pharma Inc
2-5-1, Nihombashihon-cho
Phone: +81 332443000p:+81 332443000 CHUO-KU, TKY  103-8411  Japan Ticker: 45034503
Business Summary
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
2835 In vitro and in vivo diagnostic substances
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chairman of the Board of Directors, Representative Director KenjiYasukawa 63 4/1/2023 6/19/2017
President, Chief Executive Officer, Representative Director NaokiOkamura 60 4/1/2023 6/1/2016
Vice President, Chief People Officer, Chief Ethics & Compliance Officer, Representative Director KatsuyoshiSugita 55 6/22/2023 10/1/2022
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ASTELLAS PHARMA INC.
Astellas Ireland Co., Ltd. Damastown Road Dublin Ireland
Ogeda SA 47 Rue Adrienne Bolland Gosselies Belgium
11 additional Subsidiary records available in full report.

Business Names
Business Name
4503
Agensys, Inc.
ALPMF
43 additional Business Names available in full report.

General Information
Number of Employees: 14,484 (As of 3/31/2023)
Outstanding Shares: 1,792,986,423 (As of 12/31/2023)
Shareholders: 112,732
Stock Exchange: TYO


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024